BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18621031)

  • 1. The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.
    Wu ZL; O'Kane TM; Connors TJ; Marino MJ; Schaffhauser H
    Brain Res; 2008 Aug; 1227():42-51. PubMed ID: 18621031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of gonadotropin alpha-subunit gene by phosphatidylinositol 3-kinase inhibitors in clonal gonadotroph cells.
    Kanasaki H; Mutiara S; Oride A; Miyazaki K
    Neuro Endocrinol Lett; 2008 Aug; 29(4):529-35. PubMed ID: 18766138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter.
    Atkinson BN; Bell SC; De Vivo M; Kowalski LR; Lechner SM; Ognyanov VI; Tham CS; Tsai C; Jia J; Ashton D; Klitenick MA
    Mol Pharmacol; 2001 Dec; 60(6):1414-20. PubMed ID: 11723250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.
    Galaria II; Nicholl SM; Roztocil E; Davies MG
    J Surg Res; 2005 Jul; 127(1):46-52. PubMed ID: 15964303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
    Hemström TH; Sandström M; Zhivotovsky B
    Int J Cancer; 2006 Sep; 119(5):1028-38. PubMed ID: 16570272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of typical and atypical antipsychotics on human glycine transporters.
    Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
    Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PI3-kinase inhibitors LY294002 and wortmannin have different effects on proliferation of murine embryonic stem cells].
    Lianguzova MS; Chuĭkin IA; Nordheim A; Pospelov VA
    Tsitologiia; 2006; 48(7):560-8. PubMed ID: 17087147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver Ntcp.
    Webster CR; Anwer MS
    Am J Physiol; 1999 Dec; 277(6):G1165-72. PubMed ID: 10600813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signaling pathway.
    Cui XL; Schlesier AM; Fisher EL; Cerqueira C; Ferraris RP
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1310-20. PubMed ID: 15691865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
    Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
    Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin.
    Adi S; Wu NY; Rosenthal SM
    Endocrinology; 2001 Jan; 142(1):498-501. PubMed ID: 11145615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features.
    Liu QR; López-Corcuera B; Mandiyan S; Nelson H; Nelson N
    J Biol Chem; 1993 Oct; 268(30):22802-8. PubMed ID: 8226790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices.
    Huang H; Barakat L; Wang D; Bordey A
    J Physiol; 2004 Nov; 560(Pt 3):721-36. PubMed ID: 15331688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a scintillation proximity assay for analysis of Na+/Cl- -dependent neurotransmitter transporter activity.
    Williams JB; Mallorga PJ; Lemaire W; Williams DL; Na S; Patel S; Conn PJ; Pettibone DJ; Austin C; Sur C
    Anal Biochem; 2003 Oct; 321(1):31-7. PubMed ID: 12963052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.